SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001178913-12-000435
Filing Date
2012-02-14
Accepted
2012-02-14 14:53:14
Documents
13

Document Format Files

Seq Description Document Type Size
1 POS AM zk1211028.htm POS AM 2317652
2 EXHIBIT 23.1 exhibit_23-1.htm EX-23.1 4814
3 EXHIBIT 23.2 exhibit_23-2.htm EX-23.2 4373
10 oramed.jpg GRAPHIC 3111
11 malon.jpg GRAPHIC 9099
12 footer.jpg GRAPHIC 17909
13 pwc.jpg GRAPHIC 2249
  Complete submission text file 0001178913-12-000435.txt   3721238

Data Files

Seq Description Document Type Size
4 INSTANCE DOCUMENT ormp-20120214.xml EX-101.INS 159951
5 TAXONOMY EXTENSION SCHEMA ormp-20120214.xsd EX-101.SCH 16109
6 TAXONOMY EXTENSION CALCULATION LINKBASE ormp-20120214_cal.xml EX-101.CAL 37761
7 TAXONOMY EXTENSION LABEL LINKBASE ormp-20120214_lab.xml EX-101.LAB 237584
8 TAXONOMY EXTENSION PRESENTATION LINKBASE ormp-20120214_pre.xml EX-101.PRE 94527
9 TAXONOMY EXTENSION DEFINITION LINKBASE ormp-20120214_def.xml EX-101.DEF 20831
Mailing Address 2 ELZA STREET JERUSALEM L3 93706
Business Address 2 ELZA STREET JERUSALEM L3 93706 011 972-54-7909058
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: NV | Fiscal Year End: 0831
Type: POS AM | Act: 33 | File No.: 333-175216 | Film No.: 12608158
SIC: 2834 Pharmaceutical Preparations